140 related articles for article (PubMed ID: 10843430)
1. Reduction of side-effects from ultrarush immunotherapy with honeybee venom by pretreatment with fexofenadine: a double-blind, placebo-controlled trial.
Reimers A; Hari Y; Müller U
Allergy; 2000 May; 55(5):484-8. PubMed ID: 10843430
[TBL] [Abstract][Full Text] [Related]
2. Reduction of side effects from rush-immunotherapy with honey bee venom by pretreatment with terfenadine.
Berchtold E; Maibach R; Müller U
Clin Exp Allergy; 1992 Jan; 22(1):59-65. PubMed ID: 1551035
[TBL] [Abstract][Full Text] [Related]
3. [Chronic idiopathic urticaria: effectiveness of fexofenadine. A double-blind, placebo controlled study with 21 patients].
Degonda M; Pichler WJ; Bircher A; Helbling A
Praxis (Bern 1994); 2002 Apr; 91(15):637-43. PubMed ID: 12014063
[TBL] [Abstract][Full Text] [Related]
4. Ultrarush venom desensitization after systemic reactions during conventional venom immunotherapy.
Oren E; Chegini S; Hamilos DL
Ann Allergy Asthma Immunol; 2006 Nov; 97(5):606-10. PubMed ID: 17165267
[TBL] [Abstract][Full Text] [Related]
5. Addition of fexofenadine to a topical corticosteroid reduces the pruritus associated with atopic dermatitis in a 1-week randomized, multicentre, double-blind, placebo-controlled, parallel-group study.
Kawashima M; Tango T; Noguchi T; Inagi M; Nakagawa H; Harada S
Br J Dermatol; 2003 Jun; 148(6):1212-21. PubMed ID: 12828751
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of antihistamine pretreatment in the prevention of adverse reactions to Hymenoptera immunotherapy: a prospective, randomized, placebo-controlled trial.
Brockow K; Kiehn M; Riethmüller C; Vieluf D; Berger J; Ring J
J Allergy Clin Immunol; 1997 Oct; 100(4):458-63. PubMed ID: 9338537
[TBL] [Abstract][Full Text] [Related]
7. Fexofenadine HCl is safe and effective for treatment of chronic idiopathic urticaria.
Nelson HS; Reynolds R; Mason J
Ann Allergy Asthma Immunol; 2000 May; 84(5):517-22. PubMed ID: 10831005
[TBL] [Abstract][Full Text] [Related]
8. Specific ultrarush desensitization in Hymenoptera venom-allergic patients.
Schiavino D; Nucera E; Pollastrini E; De Pasquale T; Buonomo A; Bartolozzi F; Lombardo C; Roncallo C; Patriarca G
Ann Allergy Asthma Immunol; 2004 Apr; 92(4):409-13. PubMed ID: 15104191
[TBL] [Abstract][Full Text] [Related]
9. New developments in the diagnosis and treatment of hymenoptera venom allergy.
Müller UR
Int Arch Allergy Immunol; 2001 Apr; 124(4):447-53. PubMed ID: 11340327
[TBL] [Abstract][Full Text] [Related]
10. Safety of specific immunotherapy using a four-hour ultra-rush induction scheme in bee and wasp allergy.
Roll A; Hofbauer G; Ballmer-Weber BK; Schmid-Grendelmeier P
J Investig Allergol Clin Immunol; 2006; 16(2):79-85. PubMed ID: 16689180
[TBL] [Abstract][Full Text] [Related]
11. Double-blind, placebo-controlled study comparing the efficacy and safety of fexofenadine hydrochloride (120 and 180 mg once daily) and cetirizine in seasonal allergic rhinitis.
Howarth PH; Stern MA; Roi L; Reynolds R; Bousquet J
J Allergy Clin Immunol; 1999 Nov; 104(5):927-33. PubMed ID: 10550734
[TBL] [Abstract][Full Text] [Related]
12. Randomized double-blind comparison of cetirizine and fexofenadine after pollen challenge in the Environmental Exposure Unit: duration of effect in subjects with seasonal allergic rhinitis.
Day JH; Briscoe MP; Rafeiro E; Hewlett D; Chapman D; Kramer B
Allergy Asthma Proc; 2004; 25(1):59-68. PubMed ID: 15055564
[TBL] [Abstract][Full Text] [Related]
13. A double-blind, placebo-controlled trial of fexofenadine HCl in the treatment of chronic idiopathic urticaria.
Finn AF; Kaplan AP; Fretwell R; Qu R; Long J
J Allergy Clin Immunol; 1999 Nov; 104(5):1071-8. PubMed ID: 10550755
[TBL] [Abstract][Full Text] [Related]
14. Clinical and immunologic effects of H1 antihistamine preventive medication during honeybee venom immunotherapy.
Müller UR; Jutel M; Reimers A; Zumkehr J; Huber C; Kriegel C; Steiner U; Haeberli G; Akdis M; Helbling A; Schnyder B; Blaser K; Akdis C
J Allergy Clin Immunol; 2008 Nov; 122(5):1001-1007.e4. PubMed ID: 18845330
[TBL] [Abstract][Full Text] [Related]
15. Fexofenadine: a review of its use in the management of seasonal allergic rhinitis and chronic idiopathic urticaria.
Simpson K; Jarvis B
Drugs; 2000 Feb; 59(2):301-21. PubMed ID: 10730552
[TBL] [Abstract][Full Text] [Related]
16. Rush Hymenoptera venom immunotherapy: a safe and practical protocol for high-risk patients.
Sturm G; Kränke B; Rudolph C; Aberer W
J Allergy Clin Immunol; 2002 Dec; 110(6):928-33. PubMed ID: 12464961
[TBL] [Abstract][Full Text] [Related]
17. Immunotherapy with honeybee venom and yellow jacket venom is different regarding efficacy and safety.
Müller U; Helbling A; Berchtold E
J Allergy Clin Immunol; 1992 Feb; 89(2):529-35. PubMed ID: 1740583
[TBL] [Abstract][Full Text] [Related]
18. Fexofenadine is efficacious and safe in children (aged 6-11 years) with seasonal allergic rhinitis.
Wahn U; Meltzer EO; Finn AF; Kowalski ML; Decosta P; Hedlin G; Scheinmann P; Bachert C; Rosado Pinto JE; Baena-Cagnani C; Potter P; Simons FE; Ruuth E
J Allergy Clin Immunol; 2003 Apr; 111(4):763-9. PubMed ID: 12704355
[TBL] [Abstract][Full Text] [Related]
19. Case report of venom immunotherapy for a patient with large local reactions.
Hamilton RG; Golden DB; Kagey-Sobotka A; Lichtenstein LM
Ann Allergy Asthma Immunol; 2001 Aug; 87(2):134-7. PubMed ID: 11527245
[TBL] [Abstract][Full Text] [Related]
20. Once-daily fexofenadine HCl improves quality of life and reduces work and activity impairment in patients with seasonal allergic rhinitis.
Meltzer EO; Casale TB; Nathan RA; Thompson AK
Ann Allergy Asthma Immunol; 1999 Oct; 83(4):311-7. PubMed ID: 10541423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
